Shares of Pharma Mar (OTCMKTS:PHMMF – Get Free Report) gapped up prior to trading on Monday. The stock had previously closed at $70.70, but opened at $75.05. Pharma Mar shares last traded at $75.05, with a volume of 100 shares traded.
Pharma Mar Price Performance
The stock has a 50 day moving average of $90.65 and a 200-day moving average of $92.74.
About Pharma Mar
PharmaMar is a Spanish biopharmaceutical company focused on discovering, developing and commercializing medicines for oncology. Its research draws on marine organisms as a source of compounds with potential anticancer properties. The company’s oncology portfolio includes Yondelis (trabectedin), used to treat certain soft-tissue sarcomas and ovarian cancer, and Zepzelca (lurbinectedin), used to treat small-cell lung cancer in certain markets. PharmaMar also conducts research into new cancer treatments and works with commercial partners to bring its medicines to patients in different geographies.
Recommended Stories
- Five stocks we like better than Pharma Mar
- Alphabet Escalates AI Chip Rivalry With NVIDIA
- Amazon’s Rally Is Outpacing Big Tech, But Can AWS Justify the AI Spending?
- 3 Stocks Wall Street Likes More Than the Market Does
- Anthropic’s Trillion-Dollar IPO Could Give Cloud Giants a Double Win
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
